Clinical trial
A Multi-center, Randomized, Double-blind, Parallel, Phase 2 Clinical Trial to Compare and Evaluate the Efficacy and Safety of SPC1001 and Monotherapy in Patients With Essential Hypertension
NCT06212648 is registered in ClinicalTrials.gov with Shin Poong Pharmaceutical Co. Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multi-center, Randomized, Double-blind, Parallel, Phase 2 Clinical Trial to Compare and Evaluate the Efficacy and Safety of SPC1001 and Monotherapy in Patients With Essential Hypertension
- Lead sponsor
- Shin Poong Pharmaceutical Co. Ltd.
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- March 25, 2022
- Completion date
- January 27, 2023
- Enrollment
- 253 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.